1. Home
  2. DNA vs BVS Comparison

DNA vs BVS Comparison

Compare DNA & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

HOLD

Current Price

$9.20

Market Cap

562.3M

Sector

Health Care

ML Signal

HOLD

Logo Bioventus Inc.

BVS

Bioventus Inc.

HOLD

Current Price

$7.09

Market Cap

508.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DNA
BVS
Founded
2008
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
562.3M
508.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
DNA
BVS
Price
$9.20
$7.09
Analyst Decision
Strong Sell
Buy
Analyst Count
1
3
Target Price
$9.00
$13.33
AVG Volume (30 Days)
1.2M
321.3K
Earning Date
11-06-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.15
Revenue
$180,606,000.00
$563,829,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$7.28
$7.11
P/E Ratio
N/A
$46.17
Revenue Growth
N/A
1.58
52 Week Low
$5.00
$5.81
52 Week High
$17.58
$11.89

Technical Indicators

Market Signals
Indicator
DNA
BVS
Relative Strength Index (RSI) 45.00 45.51
Support Level $8.56 $7.39
Resistance Level $9.38 $7.66
Average True Range (ATR) 0.55 0.39
MACD 0.26 -0.01
Stochastic Oscillator 69.31 45.49

Price Performance

Historical Comparison
DNA
BVS

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

About BVS Bioventus Inc.

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

Share on Social Networks: